Fritextsökning
Innehållstyper
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
KI i open innovation-samarbete
Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
De ska basa över Scilifelab
I dag tog regeringen beslut om hur forskningscentrumet Scilifelab ska styras.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Hur ska antalet kliniska prövningar öka i Sverige?
"Något händer under vägen från det vi fått godkännande tills första patient rekryteras." skriver Helena Lomberg, krönikör och senior konsult inom kliniska prövningar.
-
Första cancerlinjen sekvenserad
- Kartläggningen visar att en del av en kromosom är borta, vilket kan ge en fingervisning om hur cancer uppstår, säger en av forskarna.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Ny chef för europeiskt smittskydd
Den nederländske mikrobiologen tillträder som ECDC:s nye chef den första maj.
-
Algoritmer i stället för provrör
Mitt i Stockholm city jobbar drygt 70 personer med att ta fram och förfina mjukvaran till dosplaneringssystemet Raystation för strålterapi mot cancer.
-
It-lösning avgörande för jättestudien Lifegene
En halv miljon svenskar ska delta i den långsiktiga befolkningsstudien Lifegene. »Det här projektet hade inte varit möjligt utan det it-system vi byggt upp - de...
-
Tikomed förbereder kommersialisering
Forskningsbolaget stärker styrelsen i samband med att företaget går in i en ny fas.
BREAKING